Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the joint pain injections market size evolved in recent years?

In recent years, there has been quick expansion in the market size for joint pain injections. It is expected to escalate from a value of $5.6 billion in 2024 to $6.17 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 10.1%. The growth recorded during the historic phase is due to factors such as a rise in the elderly population, incidence of arthritis, global health efforts, increased digitalization in healthcare, and increasing awareness surrounding chronic pain management.

What are the predictions for the joint pain injections market size in the coming years?

In the upcoming years, the market size for joint pain injections is predicted to experience quick growth, reaching a value of $9.81 billion by 2029, with a compound annual growth rate (CAGR) of 12.3%. Factors contributing to the growth during the forecast period include the broadening of telehealth services, customized pain management, educating and empowering patients, sustainable healthcare practices, and providing nutritional support. Key trends detected during the forecast period involve regenerative medicine, personalized pain management, cutting-edge injection materials, rehabilitation technologies, and injections enhanced by artificial intelligence.

Get your joint pain injections market report here!

https://www.thebusinessresearchcompany.com/report/joint-pain-injections-global-market-report

What key factors are fueling the growth of the joint pain injections market?

The growing incidence of arthritis and musculoskeletal ailments is driving the expansion of the joint pain injections market. These disorders are globally the leading cause of disability, with lower back pain being the principal cause of disability in 160 nations. For relief from pain and inflammatory conditions, patients opt for injections. For example, as per the Australian Institute of Health and Welfare, a governmental body based in Australia, in June 2023, rheumatoid arthritis accounted for 2.0% of the total disease burden and 16% of the overall burden associated with musculoskeletal ailments. In 2022, there were 1,322 deaths, which corresponds to 5.1 deaths per 100,000 people or 0.7% of all deaths, attributed to it. Thus, the escalating occurrence of arthritis and musculoskeletal disorders is propelling the joint pain injections market.

How is the global joint pain injections market divided into key segments?

The joint pain injections market covered in this report is segmented –

1) By Type Of Injection: Steroid Joint Injection, Hyaluronic Acid Injections, Platelet-Rich Plasma (PRP) Injections, Placental Tissue Matrix (PTM) Injections, Other Type Of Injections

2) By Joint Type: Hip Joint, Knee And Ankle, Shoulder And Elbow, Facet Joints Of The Spine, Other Joint Types

3) By Distribution channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Steroid Joint Injection: Corticosteroid Injections, Combination Steroid Injections

2) By Hyaluronic Acid Injections: Single-Dose Hyaluronic Acid Injections, Multi-Dose Hyaluronic Acid Injections

3) By Platelet-Rich Plasma (PRP) Injections: Autologous PRP Injections, Allogeneic PRP Injections

4) By Placental Tissue Matrix (PTM) Injections: Amniotic Fluid Injections, Placental Derived Cell Injections

5) By Other Types of Injections: Bone Marrow Aspirate Concentrate (BMAC) Injections, Stem Cell Injections, Genetically Engineered Cell Injections

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6482&type=smp

Who are the key firms paving the way for growth in the joint pain injections market?

Major companies operating in the joint pain injections market include Seikagaku Corporation, Flexion Therapeutics Inc., Zimmer Biomet Holdings Inc., Sanofi S.A., Anika Therapeutics Inc., Abbvie Inc., Bioventus Inc., Eli Lilly and Company, Ferring Pharmaceuticals Inc., Pfizer Inc., Teva Pharmaceutical Industries Limited, Johnson & Johnson Services Ltd., Merck & Co. Inc., GlaxoSmithKline plc, Novartis AG, AstraZeneca plc, Roche Holding AG, Bristol-Myers Squibb Company, Boehringer Ingelheim International GmbH, Takeda Pharmaceutical Company Limited, Bayer AG, Astellas Pharma Inc., Daiichi Sankyo Company Limited, Eisai Co. Ltd., Ipsen SA, Mallinckrodt Pharmaceuticals Ltd., Mylan N.V., Sun Pharmaceutical Industries Ltd., Wockhardt Ltd., Zydus Lifesciences Limited

Which trends are expected to transform the joint pain injections market?

Major firms in the joint pain injection sector are directing their efforts towards the creation of novel solutions such as single-injection formulations to increase patient convenience. A single-injection formulation is a unique drug delivery approach that enables a particular dosage of medication to be administered through a single injection, assuring consistent therapeutic effects over an extended time without requiring numerous doses. For example, LG Chem Ltd., a chemical corporation based in South Korea, unveiled Synovian in July 2024, a breakthrough treatment for knee osteoarthritis. This treatment introduced a convenient single-injection approach, a first in China. The product is positioned to capture a significant share in a market worth estimated KRW 200 billion (around USD 150 million). It highlights creativity in meeting patient needs through its use of exclusive technology, focusing on delivering effective relief with reduced administration burden.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6482

What regions are contributing significantly to the growth of the joint pain injections market?

North America was the largest region in the joint pain injections market in 2024. The regions covered in the joint pain injections market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Browse Through More Similar Reports By The Business Research Company:

Electronic Design Automation Software Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/electronic-design-automation-software-global-market-report

Product Engineering Services Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/product-engineering-services-global-market-report

Network Engineering Services Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/network-engineering-services-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: